Cinnamon-sugar-control-health

Can Cinnamon Help Protect You From Cancer?

Posted by Cathy on

University of Arizona College of Pharmacy Researchers and the UA Cancer Center say a compound found in cinnamon is a potent colorectal cancer preventor.

New research suggests eating cinnamon may help prevent colorectal cancer, at least in mice.

Previous research has linked this spice to blood pressure reduction and blood sugar control.

Traditional Chinese Medicine (TCM) has used both the cinnamon tree bark and cinnamon tree branches for over a thousand years.

The bark of the tree is known as Gui Zhi and used in Chinese herbal formulations as a warming and dispersing herb. It helps protect against catching a cold and it can facilitate at warming the Qi, or energy of the body.

Researchers at Arizona College of Pharmacy found the compound that gives cinnamon its distinctive smell and flavor, cinnamaldehyde, also seems to protect rodents against colorectal cancer.

“This is a significant finding,” UA Cancer Center researcher Dr. Donna Zhang, said in a press release. “The next steps are to see if the spice alone can protect against cancer, and see if results can be replicated in people.”

“Can cinnamon do it, now that we know pure cinnamaldehyde can?” he said. “And can we use cinnamaldehyde or cinnamon as a weapon to go after other major diseases, such as inflammatory dysregulation and diabetes? “

Chinese herbs like cinnamon have always been used in TCM with other herbs in synergistic combinations. Using this Chinese herb or any others as a single herb should only be done under the care of a professional trained in Chinese medicine or herbal medicine.  In TCM, Chinese herbs are most often combined to enhance or create an entourage effect for the desired action and to minimize any potential side effects.  Should you have any questions about cinnamon or other Chinese herbs,   get in touch with Cathy at Pacific Herbs for a free consultation at 877-818-9990.

Chinese Herbs For Brain Cancer

Posted by Cathy on

Natural alternative for brain cancer Could it really be possible the compound known as indirubin, one of the active ingredients in traditional Chinese herbs could block the growth of glioblastoma brain tumors? 

U.S. researchers at the Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, says YES, the Chinese herbs have proven this in mice, and now research will proceed with humans.

The Chinese herb formula known as Dang Gui Long Hui Wan consists of 10 herbs which was originally published in a Chinese text named the Dan Xi Xin Fa (Dan Xi's Heart Approach) in 1347 CE.  The same Chinese herbal medicine formula has been used for treatment of chronic myelogenous leukemia (CML).1

The findings on indirubin and this novel therapeutic strategy for brain tumors was recently published in the Journal Cancer Research.  Although research on indirubins has been ongoing for years this is the  first time indirubin drugs  have improved survival in glioblastoma and these agents were found to inhibit two of the most important hallmarks of this malignancy, tumor cell invasion and angiogenesis.

This is incredible news for the approximately 13,000 Americans who die each year due to glioblastoma. "Overall, our findings suggest that indirubins reduce tumor invasion and tumor vasculature because of their antimigratory  effects on both tumor and endothelial cells," said  Antonio Chiocca  MD. 

(In memory of David Servan-Schreiber, Author of  Anticancer.  "Death is part of life. It happens to everyone. Profit from now, do the important things."

References:

1. Memorial Sloane Kettering Cancer Center clinical summary of Indirubin extract:   http://www.mskcc.org/mskcc/html/69262.cfm

2.  American Assoc. of Cancer Research:     http://cancerres.aacrjournals.org/content/early/2011/06/21/0008-5472.CAN-10-3026

"Indirubins decrease glioma invasion by blocking migratory phenotypes in both the tumor and stromal endothelial cell compartments" Shante Williams, Michal Nowicki, Fang Liu, Rachael Press, Jakub Godlewki, Mahmoud Abdel-Rasoul, Balveen Kaur, Soledad Bernandez, Antonio Chiocca and Sean Lawle